Kang W W, Han H D, Lyu T F, Song Y
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing210016, China.
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Dec 12;47(12):1211-1216. doi: 10.3670/cma.j.cn112147-20240722-00422.
Lung cancer is the malignant tumor with the highest morbidity and mortality in the world. The number of new cases and deaths of lung cancer in China ranked first in all malignant tumors. Lung cancer screening plays an important role in improving the survival rate and quality of life of patients. However, there are several challenges of lung cancer screening in China, including identifying the target population, selecting appropriate screening methods, managing screening results, and maintaining quality control. In the era of precision medicine, combining artificial intelligence (AI) and big data to develop predictive models can significantly enhance the accuracy and effectiveness of lung cancer screening. To develop a lung cancer screening strategy tailored to the Chinese population, further exploration of precision medicine is essential.
